title: Adverse effects of OKT3 therapy: increased risk with impaired renal function.
authors.affiliation: Department of Surgery, Leicester General Hospital, United Kingdom.
authors.forename: E O
authors.initials: EO
authors.lastname: Kehinde
authors.forename: S D
authors.initials: SD
authors.lastname: Scriven
authors.forename: J
authors.initials: J
authors.lastname: Feehally
authors.forename: P S
authors.initials: PS
authors.lastname: Veitch
authors.forename: K
authors.initials: K
authors.lastname: Varty
authors.forename: P R
authors.initials: PR
authors.lastname: Bell
mesh_terms: D000328:Adult; D002102:Cadaver; D004351:Drug Resistance; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000009:adverse effects*; D012189:Retrospective Studies; D013256:Steroids / Q000627:therapeutic use; D014019:Tissue Donors
chemical_list: D016853:Muromonab-CD3; D013256:Steroids